載入...
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
Efficacy is the main objective of antiretroviral treatment and adherence is one of the cornerstones to achieve it. For this reason, treatment simplification is of key importance with regard to antiretroviral regimens. Rezolsta® (darunavir/cobicistat) is the first fixed-dose combination containing a...
Na minha lista:
| 發表在: | HIV AIDS (Auckl) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5098528/ https://ncbi.nlm.nih.gov/pubmed/27843352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S56158 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|